Lambert Eaton Myasthenic Syndrome Market is Driven by Rising Awareness and Early Disease Detection
Lambert-Eaton Myasthenic Syndrome (LEMS) is a rare autoimmune disorder that affects the neuromuscular junction, causing muscle weakness and other neurological symptoms. The LEMS treatment market encompasses various therapeutic approaches, including immunosuppressive medications, aminopyridines, and intravenous immunoglobulin therapy. These treatments are crucial in managing symptoms and...
0 Reacties 0 aandelen 181 Views 0 voorbeeld